SALT LAKE CITY, Dec. 17, 2009 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present an overview of the Company at the 28th Annual J.P. Morgan Healthcare Conference, at 10:30 a.m. Pacific on January 13, 2010, at the Westin St. Francis Hotel in San Francisco, California.
